mdlinx mdlinx
Latest (46) Full Text Focus on MI Article Summary

Long-term effects of weight-reducing diets in hypertensive patients
Cochrane Reviews, 09/12/2011  Clinical Article

Siebenhofer A et al. - In patients with primary hypertension, weight loss diets reduced body weight and blood pressure, however the magnitude of the effects are uncertain as a result of the small number of patients and studies that could be included in the analyses. It is not known whether weight loss reduces mortality and morbidity. No useful information on adverse effects was reported in the relevant trials.

Methods
  • Studies were obtained from computerised searches of Ovid MEDLINE, EMBASE, CENTRAL and from searches in reference lists and systematic reviews.
  • Randomised controlled trials (RCT) in adult hypertensive patients were included if they had a study duration of at least 24 weeks and compared weight reducing dietary interventions to no dietary intervention in adult patients with primary hypertension.
  • Two authors independently assessed risk of bias and extracted data.
  • Studies were pooled using fixed-effect meta-analysis.
  • In case of moderate or larger heterogeneity as measured by Higgins I2, a random effects model was used.

Results
  • Eight studies involving a total of 2100 participants with high blood pressure and a mean age of 45 to 66 years met the inclusion criteria.
  • Mean treatment duration was 6 to 36 months.
  • No study included mortality as a pre-defined outcome.
  • One RCT evaluated the effects of dietary weight loss on a combined endpoint, consisting of the necessity of reinstating antihypertensive therapy and severe cardiovascular complications.
  • In this RCT weight reducing diet lowered the endpoint, hazard ratio 0.70 (95% confidence interval [CI], 0.57 to 0.87) compared to no diet.
  • None of the studies evaluated adverse events as designated in this protocol.
  • Blood pressure was reduced in patients assigned to weight loss diets as compared to controls: systolic blood pressure (SBP): weighted mean difference (WMD): -4.5 mm Hg; 95% CI, -7.2 to -1.8 mm Hg (3 of 8 studies included in analysis), and diastolic blood pressure (DBP): WMD -3.2 mm Hg; 95% CI, -4.8 to -1.5 mm Hg (3 of 8 studies included in analysis).
  • Patients' body weight was also reduced in dietary weight loss groups as compared to controls, WMD of -4.0 kg (95% CI: -4.8 to -3.2) (5 of 8 studies included in analysis).
  • Two studies used withdrawal of antihypertensive medication as their primary outcome.
  • Even though this was not considered a relevant outcome for this review, the results of these studies strengthen the finding of reduction of blood pressure by dietary weight loss interventions.

Read this article in Cochrane Reviews read MDLinx article: Long-term effects of weight-reducing diets in hypertensive patients

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

Last month's top read Top 50 of 2011

1 Comparison of alternate day atorvastatin treatment to daily treatment in maintaining LDL-Cholesterol targets in patients with variable coronary risk profile Journal of Cardiovascular Pharmacology, April 2, 2012    Clinical Article

2 Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials Full Text Lipids in Health and Disease, April 5, 2012    Free full text

3 Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the lunar study) The American Journal of Cardiology, April 17, 2012    Clinical Article

4 Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation British Journal of Clinical Pharmacology, April 24, 2012    Clinical Article

5 Evidence-based Use of Statins for Primary Prevention of Cardiovascular Disease American Journal of Medicine, April 9, 2012    Evidence Based Medicine    Clinical Article

6 Statins as a possible cause of inflammatory and necrotizing myopathies Atherosclerosis, April 23, 2012    Clinical Article

7 Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure JAMA, April 12, 2012    Clinical Article

8 Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias Pharmacoepidemiology and Drug Safety, April 4, 2012    Clinical Article

9 Effects of Celecoxib On Restenosis after Coronary Intervention and Evolution of Atherosclerosis (Mini-COREA) Trial: celecoxib, a double-edged sword for patients with angina European Heart Journal, March 12, 2012    Clinical Article

10 Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheterization and Cardiovascular Interventions, April 19, 2012    Clinical Article

11 Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease Heart and Vessels, March 22, 2012    Clinical Article

12 Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study European Heart Journal, April 25, 2012    Clinical Article

13 On-treatment non–high-density lipoprotein cholesterol, apolipoprotein b, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy JACC - Journal of the American College of Cardiology, April 18, 2012    Clinical Article

14 STAR VaS - Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery Canadian Journal of Anesthesia, April 16, 2012    Clinical Article

15 Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) European Heart Journal, April 27, 2012    Clinical Article

16 Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the truth study) The American Journal of Cardiology, April 26, 2012    Clinical Article

17 Statin therapy is associated with aneurysm sac regression after endovascular aortic repair Journal of Vascular Surgery, April 3, 2012    Clinical Article

18 Vitamin D deficiency, CD4+CD28null cells and Accelerated Atherosclerosis in Chronic Kidney Disease Nephrology, April 13, 2012    Clinical Article

19 Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials Atherosclerosis, April 4, 2012

20 Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: The potential role for regulatory T cells Atherosclerosis, April 20, 2012    Clinical Article

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore

Other Topics in Cardiology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close